138 related articles for article (PubMed ID: 14871825)
1. TIMP-1 alters susceptibility to carcinogenesis.
Rhee JS; Diaz R; Korets L; Hodgson JG; Coussens LM
Cancer Res; 2004 Feb; 64(3):952-61. PubMed ID: 14871825
[TBL] [Abstract][Full Text] [Related]
2. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing.
Elson DA; Ryan HE; Snow JW; Johnson R; Arbeit JM
Cancer Res; 2000 Nov; 60(21):6189-95. PubMed ID: 11085544
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
4. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.
Coussens LM; Tinkle CL; Hanahan D; Werb Z
Cell; 2000 Oct; 103(3):481-90. PubMed ID: 11081634
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice.
Arbeit JM; Olson DC; Hanahan D
Oncogene; 1996 Nov; 13(9):1847-57. PubMed ID: 8934530
[TBL] [Abstract][Full Text] [Related]
6. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
Owens DM; Watt FM
Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
[TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated expression of microRNA-150 in human papillomavirus-induced lesions of K14-HPV16 transgenic mice.
Santos JMO; Fernandes M; Araújo R; Sousa H; Ribeiro J; Bastos MMSM; Oliveira PA; Carmo D; Casaca F; Silva S; Teixeira AL; Gil da Costa RM; Medeiros R
Life Sci; 2017 Apr; 175():31-36. PubMed ID: 28302562
[TBL] [Abstract][Full Text] [Related]
11. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice.
Arbeit JM; Münger K; Howley PM; Hanahan D
J Virol; 1994 Jul; 68(7):4358-68. PubMed ID: 7515971
[TBL] [Abstract][Full Text] [Related]
12. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice.
Coussens LM; Hanahan D; Arbeit JM
Am J Pathol; 1996 Dec; 149(6):1899-917. PubMed ID: 8952526
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Suzuki M; Iizasa T; Fujisawa T; Baba M; Yamaguchi Y; Kimura H; Suzuki H
Invasion Metastasis; 1998-1999; 18(3):134-41. PubMed ID: 10474026
[TBL] [Abstract][Full Text] [Related]
14. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: a potential oncogenic activity of tissue inhibitor of metalloproteinase-1.
Liu XW; Taube ME; Jung KK; Dong Z; Lee YJ; Roshy S; Sloane BF; Fridman R; Kim HR
Cancer Res; 2005 Feb; 65(3):898-906. PubMed ID: 15705888
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
16. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
[TBL] [Abstract][Full Text] [Related]
17. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
[TBL] [Abstract][Full Text] [Related]
18. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
19. Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model.
Ikenaka Y; Yoshiji H; Kuriyama S; Yoshii J; Noguchi R; Tsujinoue H; Yanase K; Namisaki T; Imazu H; Masaki T; Fukui H
Int J Cancer; 2003 Jun; 105(3):340-6. PubMed ID: 12704667
[TBL] [Abstract][Full Text] [Related]
20. Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice.
Arbeit JM; Riley RR; Huey B; Porter C; Kelloff G; Lubet R; Ward JM; Pinkel D
Cancer Res; 1999 Aug; 59(15):3610-20. PubMed ID: 10446971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
